Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

1.8K
1.8K
Modeling in Therapy01:26

Modeling in Therapy

711
Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
711
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

84
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
84
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

292
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
292
Methods of Medium Optimization01:28

Methods of Medium Optimization

52
Optimizing growth media enhances microbial proliferation and maximizes product yield. Statistical experimental design methodologies provide structured and reproducible approaches, offering progressively higher levels of robustness and efficiency.The One-Factor-at-a-Time (OFAT) MethodThe One-Factor-at-a-Time (OFAT) method involves adjusting a single variable while keeping all others constant. However, it cannot detect interactions between variables, often leading to suboptimal outcomes when...
52

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MISSTE: a multiscale integrative spatial simulator for understanding the mechanisms underlying tissue ecosystems.

Computers in biology and medicine·2026
Same author

SIMCROST: A Simulator for Understanding the Spatial Regulation in Cross-Membrane Signal Transduction.

Chembiochem : a European journal of chemical biology·2026
Same author

Inferring Dynamic Information from Protein Structures by Gaussian Integrals and Deep Learning.

Bioinformatics (Oxford, England)·2026
Same author

MISSTE: a multiscale integrative spatial simulator for understanding the mechanisms underlying tissue ecosystems.

bioRxiv : the preprint server for biology·2026
Same author

IDBSpred: An intrinsically disordered binding site predictor using machine learning and protein language model.

bioRxiv : the preprint server for biology·2026
Same author

Multiscale conformational sampling of multidomain fusion proteins by a physics informed diffusion model.

bioRxiv : the preprint server for biology·2026
Same journal

Layered social competition coordinates reproductive hierarchy formation in ants.

bioRxiv : the preprint server for biology·2026
Same journal

Combination epigenetic-targeted therapy increases the immunogenicity of poorly immunogenic sarcomas.

bioRxiv : the preprint server for biology·2026
Same journal

Loss of LanC-like proteins delays post-injury regeneration of aging skeletal muscles.

bioRxiv : the preprint server for biology·2026
Same journal

Integrative Transfer Network: Deep Transfer Learning Across Populations and Prediction Targets.

bioRxiv : the preprint server for biology·2026
Same journal

Confidence-supported label-free metabolic imaging with FPhaS phase autofluorescence microscopy.

bioRxiv : the preprint server for biology·2026
Same journal

Sequence-encoded autoinhibition couples mRNA decapping activity to phase separation.

bioRxiv : the preprint server for biology·2026
See all related articles

Related Experiment Video

Updated: Apr 4, 2026

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.4K

OPTIMIS: Optimizing Personalized Therapies through Integrated Multiscale Intelligent Simulation.

Zhaoqian Su1, Yinghao Wu2

  • 1Research, Takeda Pharmaceutical Company Ltd., Cambridge, 02139, MA, USA.

Biorxiv : the Preprint Server for Biology
|April 3, 2026
PubMed
Summary
This summary is machine-generated.

This study introduces an AI framework combining stochastic and deterministic models for complex biological systems. The AI learns adaptive treatment policies, improving control rates in unstable simulations by anticipating dangerous immune reactions.

More Related Videos

Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models
14:14

Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models

Published on: August 12, 2018

9.5K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

16.5K

Related Experiment Videos

Last Updated: Apr 4, 2026

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.4K
Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models
14:14

Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models

Published on: August 12, 2018

9.5K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

16.5K

Area of Science:

  • Computational Medicine
  • Systems Biology
  • Artificial Intelligence

Background:

  • Controlling complex biological systems across scales is challenging due to molecular variability influencing macroscale behavior.
  • Deterministic models neglect molecular variability, while stochastic simulations are too slow for AI training.

Purpose of the Study:

  • To develop a novel AI framework for adaptive intervention in multiscale biological systems.
  • To enable high-throughput simulations for training artificial intelligence in computational medicine.

Main Methods:

  • Developed a hybrid AI framework combining Gillespie algorithm (microscale) and ordinary differential equations (macroscale).
  • Created a differentiable Neural Ordinary Differential Equation (Neural ODE) surrogate for fast digital twin simulations.
  • Utilized deep reinforcement learning (RL) agents to learn closed-loop treatment policies.

Main Results:

  • The AI framework successfully learned dynamic, closed-loop treatment policies for engineered cellular therapy.
  • Microscopic cellular activity was used as an early-warning signal to adjust drug dosage.
  • Improved successful control rates to over 70% in highly unstable simulated phenotypes.

Conclusions:

  • The AI framework provides a practical and generalizable approach for adaptive intervention in multiscale biological systems.
  • This computational advance facilitates controlling complex diseases by integrating molecular variability.
  • The developed framework accelerates AI training for biological system control.